ACET
Price
$2.35
Change
+$0.02 (+0.86%)
Updated
Mar 28, 1:54 PM EST
41 days until earnings call
IBRX
Price
$5.39
Change
-$0.07 (-1.28%)
Updated
Mar 28, 2:10 PM EST
40 days until earnings call
Ad is loading...

ACET vs IBRX ᐉ Comparison: Which is Better to Invest?

Header iconACET vs IBRX Comparison
Open Charts ACET vs IBRXBanner chart's image
Adicet Bio
Price$2.35
Change+$0.02 (+0.86%)
Volume$2.1K
CapitalizationN/A
ImmunityBio
Price$5.39
Change-$0.07 (-1.28%)
Volume$1K
CapitalizationN/A
View a ticker or compare two or three
ACET vs IBRX Comparison Chart

Loading...

ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACET vs. IBRX commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and IBRX is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ACET: $2.35 vs. IBRX: $5.37)
Brand notoriety: ACET and IBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 22% vs. IBRX: 78%
Market capitalization -- ACET: $190.6M vs. IBRX: $3.67B
ACET [@Biotechnology] is valued at $190.6M. IBRX’s [@Biotechnology] market capitalization is $3.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileIBRX’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • IBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 6 TA indicator(s) are bullish while IBRX’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 6 bullish, 5 bearish.
  • IBRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ACET and IBRX are a good buy in the short-term.

Price Growth

ACET (@Biotechnology) experienced а +15.20% price change this week, while IBRX (@Biotechnology) price change was -12.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.78%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +88.40%.

Reported Earning Dates

ACET is expected to report earnings on May 08, 2024.

IBRX is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACET with price predictions.
OPEN
A.I.dvisor published
a Summary for IBRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IBRX($3.67B) has a higher market cap than ACET($191M). ACET YTD gains are higher at: 22.751 vs. IBRX (8.566). ACET has higher annual earnings (EBITDA): -136.54M vs. IBRX (-436.18M). IBRX has more cash in the bank: 266M vs. ACET (160M). ACET has less debt than IBRX: ACET (20.9M) vs IBRX (727M). IBRX has higher revenues than ACET: IBRX (622K) vs ACET (0).
ACETIBRXACET / IBRX
Capitalization191M3.67B5%
EBITDA-136.54M-436.18M31%
Gain YTD22.7518.566266%
P/E Ratio6.06N/A-
Revenue0622K-
Total Cash160M266M60%
Total Debt20.9M727M3%
FUNDAMENTALS RATINGS
ACET vs IBRX: Fundamental Ratings
ACET
IBRX
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4535
P/E GROWTH RATING
1..100
31100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (38) in the Medical Distributors industry is somewhat better than the same rating for IBRX (94) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than IBRX’s over the last 12 months.

IBRX's Profit vs Risk Rating (85) in the Biotechnology industry is in the same range as ACET (100) in the Medical Distributors industry. This means that IBRX’s stock grew similarly to ACET’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as IBRX (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to IBRX’s over the last 12 months.

IBRX's Price Growth Rating (35) in the Biotechnology industry is in the same range as ACET (45) in the Medical Distributors industry. This means that IBRX’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (31) in the Medical Distributors industry is significantly better than the same rating for IBRX (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETIBRX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFMV111.291.03
+0.94%
Vanguard US Minimum Volatility ETF
RFG50.530.43
+0.85%
Invesco S&P MidCap 400® Pure Growth ETF
MUC11.030.05
+0.46%
Blackrock Muniholdings California Quality Fund
MMCA21.72N/A
N/A
IQ MacKay California Mncpl Intmdt ETF
VXZ13.62-0.04
-0.29%
iPath® B S&P 500® VIX Md-Trm Futs™ ETN

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+3.57%
OGI - ACET
41%
Loosely correlated
-14.37%
DVAX - ACET
39%
Loosely correlated
+0.32%
TERN - ACET
39%
Loosely correlated
N/A
DCPH - ACET
39%
Loosely correlated
+2.50%
CRON - ACET
36%
Loosely correlated
+2.27%
More

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with MDGL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
+6.45%
MDGL - IBRX
61%
Loosely correlated
+4.52%
AXON - IBRX
48%
Loosely correlated
-1.13%
ARRY - IBRX
41%
Loosely correlated
+6.94%
CRSP - IBRX
40%
Loosely correlated
-1.14%
NTLA - IBRX
38%
Loosely correlated
+2.82%
More